PHARPDUFA
Leniolisib
Activated Phosphoniositide 3-kinase Delta Syndrome (APDS in children 4–11) (label expansion)
Approval decisionFDA regulatory calendar
Track FDA action dates and advisory committee meetings by month. Each event links to its company, drug, indication and source-backed research record.
Use the monthly FDA calendar to review PDUFA target dates and advisory committee meetings, then open each event for drug, company, indication and source context.